Newsroom

Sorted by: Latest

-

AM Best Affirms Credit Ratings of RF&G Insurance Company Limited

MEXICO CITY--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating of B++ (Good) and the Long-Term Issuer Credit Rating of “bbb” (Good) of RF&G Insurance Company Limited (RF&G) (Belize). The outlook of these Credit Ratings (ratings) is stable. The ratings reflect RF&G’s balance sheet strength, which AM Best assesses as very strong, as well as its adequate operating performance, neutral business profile and appropriate enterprise risk management (ERM). RF&G is the l...
-

Xtrackers II UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Xtrackers II Investment company with variable capital (Société d'investissement à capital variable) Registered office: 49, avenue J.F. Kennedy, L-1855 Luxembourg R.C.S. Luxembourg B-124.284 (the “Company”) NOTICE TO SHAREHOLDERS OF THE SUB-FUNDS LISTED ON THE LONDON STOCK EXCHANGE Luxembourg, 05 February 2026 The board of directors of the Company (the “Board of Directors”) hereby informs all shareholders of the sub-funds listed in the table below (each a “Sub-Fund”, a...
-

Xtrackers UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Xtrackers Investment company with variable capital (Société d'investissement à capital variable) Registered office: 49, avenue J.F. Kennedy, L-1855 Luxembourg R.C.S. Luxembourg B-119.899 (the “Company”) NOTICE TO SHAREHOLDERS OF THE SUB-FUNDS LISTED ON THE LONDON STOCK EXCHANGE Luxembourg, 05 February 2026 The board of directors of the Company (the “Board of Directors”) hereby informs all shareholders of the sub-funds listed in the table below (each a “Sub-Fund”, and...
-

Law Offices of Howard G. Smith Encourages Picard Medical, Inc. (PMI) Shareholders To Inquire About Securities Fraud Class Action

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Picard Medical, Inc. (“Picard” or the “Company”) (NYSE: PMI) securities between September 2, 2025 and October 31, 2025, inclusive (the “Class Period”). Picard investors have until April 3, 2026 to file a lead plaintiff motion. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN PICARD MEDICAL, INC. (PMI), CONTACT THE LAW OFFICES OF HOWARD G. SMITH TO...
-

Law Offices of Howard G. Smith Encourages Richtech Robotics Inc. (RR) Shareholders To Inquire About Securities Fraud Class Action

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Richtech Robotics Inc. (“Richtech” or the “Company”) (NASDAQ: RR) securities between January 27, 2026 and 12:00 PM EST on January 29, 2026, inclusive (the “Class Period”). Richtech investors have until April 3, 2026 to file a lead plaintiff motion. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN RICHTECH ROBOTICS INC. (RR), CONTACT THE LAW OFFICE...
-

Natixis Syndicate UK Regulatory Announcement: Post-Stabilisation Announcement

LONDON--(BUSINESS WIRE)--  POST-STABILISATION ANNOUNCEMENT Date: 6th February 2026 Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful. CARAC Post-stabilisation Period Announcement Further to the pre-stabilisation period announcement dated 28th January 2026, Natixis (contact: Christopher Agathangelou; telephone: 0158550814) hereby gives notice that no stabilisation (within the meaning of Article 3.2(d) of th...
-

Rosen Law Firm Encourages GSI Technology Inc. Investors to Inquire About Securities Class Action Investigation – GSIT

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces that it is investigating potential securities claims on behalf of shareholders of GSI Technology Inc. (NASDAQ: GSIT) resulting from allegations that GSI Technology may have issued materially misleading business information to the investing public. So What: If you purchased GSI Technology securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingen...
-

OnMed Named 2026 Impact Product of the Year by Impact One Awards

NEW YORK--(BUSINESS WIRE)--OnMed Named 2026 Impact Product of the Year by Impact One Awards...
-

INVESTOR DEADLINE: Ultragenyx Pharmaceutical Inc. (RARE) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces

SAN DIEGO--(BUSINESS WIRE)--Ultragenyx allegedly misled investors about setrusumab’s potential Phase 3 study success in reducing fracture rates....
-

INVESTOR ALERT: Oracle Corporation (ORCL) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces

SAN DIEGO--(BUSINESS WIRE)--Oracle allegedly failed to disclose that its AI strategy would result in massive increases in CapEx without equivalent near-term revenue growth....